Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First 21days,Versus ASA Alone for the Acute Treatment of TIA or Minor Stroke

Next Previous
Trial Profile

Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First 21days,Versus ASA Alone for the Acute Treatment of TIA or Minor Stroke

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Ischaemic stroke; Transient ischaemic attacks
  • Focus Registrational; Therapeutic Use
  • Acronyms CASTIA; CHANCE

Most Recent Events

  • 02 Jun 2023 Results of post hoc analysis (n= 2853) assessing investigated the role of CYP2B6 polymorphisms and the efficacy of clopidogrel in patients with minor stroke or transient ischemic attack in China published in the Stroke
  • 01 Nov 2022 Results of subgroup analysis (n=3456) assessing the rebound effect after discontinuation of clopidogrel therapy in patients with TIA or stroke published in the Neurological Research
  • 01 Aug 2022 Results of post hoc analysis (n=886 ) investigating the association of different status of cerebral small vessel disease and infarction number with recurrence after acute minor stroke and transient ischaemic attack, published in the Neurological Sciences

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top